All ProductsDisplaying Products by Catalog Number (3500 - 3599)
01000200030004000500060007000800090010001100120013001400150016001700180019002000210022002300240025002600270028002900300031003200330034003500360037003800390040004100420043004400450046004700480049005000510052005300540055005600570058005900600061006200630064006500660067006800690070007100720073007400750076007700780079008000810082008300840085008600870088008900
| Cat. No. | Product Name / Activity |
|---|---|
| 3501 | Decanoyl-RVKR-CMK |
| Subtilisin/Kex2p-like proprotein convertase inhibitor | |
| 3503 | HLI 373 |
| Hdm2 inhibitor; activates p53-dependent transcription | |
| 3505 | BMS 753 |
| RARα-selective agonist | |
| 3507 | AM 80 |
| RARα agonist; anticancer agent | |
| 3509 | BMS 493 |
| Pan-RAR inverse agonist | |
| 3512 | NPE-caged-proton |
| Caged proton | |
| 3515 | FK 228 |
| Potent and selective class I histone deacetylase inhibitor; antitumor | |
| 3516 | Tunicamycin |
| Antibiotic; GlcNAc phosphotransferase inhibitor | |
| 3517 | Nebivolol hydrochloride |
| Highly selective β1-adrenoceptor antagonist | |
| 3518 | S 24795 |
| α7 nAChR partial agonist | |
| 3520 | C-type natriuretic peptide (1-22) (human, rat, swine) |
| Endogenous peptide agonist at NPR2 | |
| 3522 | Brain natriuretic peptide (1-32) (human) |
| Endogenous peptide agonist at ANP receptor A (NPR1) | |
| 3525 | ACSF (Artificial Cerebrospinal Fluid) |
| Artificial cerebrospinal fluid (ACSF) for electrophysiology; sterile and microfiltered | |
| 3528 | SCIO 469 hydrochloride |
| Selective p38 MAPK inhibitor | |
| 3529 | PD 168568 dihydrochloride |
| Potent and selective D4 antagonist | |
| 3530 | HQL 79 |
| Human hematopoietic prostaglandin D synthase (H-PGDS) inhibitor | |
| 3532 | endo-IWR 1 |
| Wnt/β-catenin signaling inhibitor; axin stabilizer | |
| 3533 | IWP 2 |
| PORCN inhibitor; inhibits Wnt processing and secretion | |
| 3534 | PNU 74654 |
| β-catenin binder; inhibits Wnt signaling | |
| 3535 | Sivelestat sodium salt |
| Selective leukocyte elastase inhibitor | |
| 3540 | Orlistat |
| Pancreatic, gastric and carboxylester lipase inhibitor; antiobesity and antihypercholesterolemic activity | |
| 3542 | CP 316819 |
| Selective glycogen phosphorylase inhibitor | |
| 3544 | KU 55933 |
| Potent and selective ATM kinase inhibitor | |
| 3545 | Histamine dihydrochloride |
| Endogenous histamine receptor agonist | |
| 3546 | (-)-Nicotine ditartrate |
| Prototypical nAChR agonist | |
| 3547 | Serotonin hydrochloride |
| Endogenous 5-HT receptor agonist | |
| 3548 | Dopamine hydrochloride |
| Endogenous agonist at dopamine D1-5 receptors | |
| 3549 | 3-Bromocytisine |
| Potent α4β4, α4β2 and α7 nAChR agonist | |
| 3550 | Melatonin |
| Endogenous hormone; agonist at MT1 and MT2 | |
| 3562 | LU AA33810 |
| Potent NPY Y5 receptor antagonist | |
| 3565 | ONO AE3 208 |
| High affinity and selective EP4 antagonist | |
| 3567 | TC-S 7003 |
| Potent Lck inhibitor | |
| 3569 | Xanomeline oxalate |
| Functionally biased muscarinic M4 receptor agonist | |
| 3570 | Z-Guggulsterone |
| Broad spectrum steroid receptor ligand. More active isomer of guggulsterone (Cat. No. 2013) | |
| 3572 | GSK 650394 |
| Serum- and glucocorticoid-regulated kinase (SGK) inhibitor | |
| 3573 | SB 612111 hydrochloride |
| Selective NOP antagonist | |
| 3574 | RuBi-Glutamate |
| Caged glutamate; excited by visible wavelengths | |
| 3576 | (±)-5'-Chloro-5'-deoxy-ENBA |
| Highly selective A1 agonist | |
| 3577 | G-1 |
| Potent and selective GPER agonist | |
| 3579 | 5-BDBD |
| Potent and selective P2X4 antagonist | |
| 3581 | C 021 dihydrochloride |
| Potent CCR4 antagonist | |
| 3586 | Sumatriptan succinate |
| 5-HT1A, 5-HT1B and 5-HT1D agonist | |
| 3591 | VO-OHpic |
| Potent PTEN inhibitor | |
| 3595 | CHR 2797 |
| Aminopeptidase inhibitor | |
| 3599 | TAK 165 |
| Potent and selective ErbB2 inhibitor |